181 related articles for article (PubMed ID: 12097790)
1. Discontinuing paroxetine: a personal account.
Shoenberger D
Psychother Psychosom; 2002; 71(4):237-8. PubMed ID: 12097790
[No Abstract] [Full Text] [Related]
2. More cases of paroxetine withdrawal syndrome.
Pacheco L; Malo P; Aragues E; Etxebeste M
Br J Psychiatry; 1996 Sep; 169(3):384. PubMed ID: 8879736
[No Abstract] [Full Text] [Related]
3. New dosage-reduction regime to avoid paroxetine discontinuation syndrome.
Pacheco Yáñez L; Malo P; Etxebeste M; Aragües E; Medrano J
Can J Psychiatry; 2003 Mar; 48(2):129-30. PubMed ID: 12655918
[No Abstract] [Full Text] [Related]
4. Withdrawal syndromes after paroxetine and sertraline discontinuation.
Fava GA; Grandi S
J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
[No Abstract] [Full Text] [Related]
5. [Withdrawal syndrome after the use of serotonin reuptake inhibitors].
Fagan M
Tidsskr Nor Laegeforen; 2000 Mar; 120(8):913-4. PubMed ID: 10795494
[TBL] [Abstract][Full Text] [Related]
6. Lhermitte's sign in paroxetine withdrawal.
Reeves RR; Pinkofsky HB
J Clin Psychopharmacol; 1996 Oct; 16(5):411-2. PubMed ID: 8889917
[No Abstract] [Full Text] [Related]
7. Discontinuation symptoms and SSRIs.
Pollock BG
J Clin Psychiatry; 1998 Oct; 59(10):535-7. PubMed ID: 9818635
[No Abstract] [Full Text] [Related]
8. [Severe withdrawal symptoms with fever during paroxetine tapering off].
Peeters FP; Zandbergen J
Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1429-31. PubMed ID: 10422558
[TBL] [Abstract][Full Text] [Related]
9. Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine.
Vandel P; Sechter D; Weiller E; Pezous N; Cabanac F; Tournoux A; Panconi E
Hum Psychopharmacol; 2004 Dec; 19(8):585-6. PubMed ID: 15570574
[No Abstract] [Full Text] [Related]
10. Discontinuation of antidepressant therapy: emerging complications and their relevance.
Thompson C
J Clin Psychiatry; 1998 Oct; 59(10):541-8. PubMed ID: 9818638
[No Abstract] [Full Text] [Related]
11. Palinopsia and paroxetine withdrawal.
Terao T
J Clin Psychiatry; 2002 Apr; 63(4):368. PubMed ID: 12000213
[No Abstract] [Full Text] [Related]
12. [Paroxetine withdrawal syndrome].
Belloeuf L; Le Jeunne C; Hugues FC
Ann Med Interne (Paris); 2000 Apr; 151 Suppl A():A52-3. PubMed ID: 10855379
[TBL] [Abstract][Full Text] [Related]
13. [Acute dystonia following paroxetine withdrawal].
Cabo-López I; García-Bermejo P; González-Roiz C; Durán-Martínez P; García-Ruiz PJ
Rev Neurol; 2008 Feb 16-29; 46(4):253-4. PubMed ID: 18327750
[No Abstract] [Full Text] [Related]
14. Selective serotonin reuptake inhibitor. Discontinuation syndrome.
Finfgeld DL
J Psychosoc Nurs Ment Health Serv; 2002 Dec; 40(12):14-8. PubMed ID: 12491870
[TBL] [Abstract][Full Text] [Related]
15. [Severe withdrawal symptoms with fever upon stopping paroxetine].
Vergouwen AC; Kuipers T
Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1794-5; author reply 1795-6. PubMed ID: 10494332
[No Abstract] [Full Text] [Related]
16. [Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].
Bryois C; Rubin C; Zbinden JD; Baumann P
Praxis (Bern 1994); 1998 Mar; 87(10):345-8. PubMed ID: 9545842
[TBL] [Abstract][Full Text] [Related]
17. Paroxetine discontinuation syndrome in association with sertindole therapy.
Walker-Kinnear M; McNaughton S
Br J Psychiatry; 1997 Apr; 170():389. PubMed ID: 9246265
[No Abstract] [Full Text] [Related]
18. Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors.
Frost L; Lal S
Am J Psychiatry; 1995 May; 152(5):810. PubMed ID: 7726327
[No Abstract] [Full Text] [Related]
19. Adverse events after the abrupt discontinuation of paroxetine.
Dominguez RA; Goodnick PJ
Pharmacotherapy; 1995; 15(6):778-80. PubMed ID: 8602387
[TBL] [Abstract][Full Text] [Related]
20. SSRI withdrawal.
Mareth TR; Brown TM
J Clin Psychiatry; 1996 Jul; 57(7):310. PubMed ID: 8666577
[No Abstract] [Full Text] [Related]
[Next] [New Search]
